Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „cariprazine“
Suchtreffer
Begriffe & Kennungen
Reagila · 4.5 · CYP2D6 inhibitors CYP2D6 mediated pathway plays a minor role in the metabolism of cariprazine, the major pathw
Eintrag öffnenReagila · 4.5 · CYP2D6 inhibitors CYP2D6 mediated pathway plays a minor role in the metabolism of cariprazine, the major pathw
Eintrag öffnenReagila · 4.5 · CYP3A4 inducers Co-administration of cariprazine with strong and moderate inducers of CYP3A4 may result in a s
Eintrag öffnenReagila · 4.5 · CYP3A4 inducers Co-administration of cariprazine with strong and moderate inducers of CYP3A4 may result in a s
Eintrag öffnenReagila · 4.5 · Given the primary central nervous system effects of cariprazine, Reagila should be used with caution in combin
Eintrag öffnenReagila · 4.5 · Given the primary central nervous system effects of cariprazine, Reagila should be used with caution in combin
Eintrag öffnenReagila · 4.5 · Hormonal contraceptives In a drug interaction study, 28 days of treatment with cariprazine at 6 mg daily had n
Eintrag öffnenReagila · 4.5 · Hormonal contraceptives In a drug interaction study, 28 days of treatment with cariprazine at 6 mg daily had n
Eintrag öffnenReagila · 4.5 · Metabolism of cariprazine and its major active metabolites, desmethyl cariprazine (DCAR) and didesmethyl carip
Eintrag öffnenReagila · 4.5 · Metabolism of cariprazine and its major active metabolites, desmethyl cariprazine (DCAR) and didesmethyl carip
Eintrag öffnenReagila · 4.5 · P-glycoprotein (P-gp) substrates Cariprazine is a P-gp inhibitor in vitro at its theoretical maximum intestina
Eintrag öffnenReagila · 4.5 · P-glycoprotein (P-gp) substrates Cariprazine is a P-gp inhibitor in vitro at its theoretical maximum intestina
Eintrag öffnenReagila · 4.5 · Potential for cariprazine to affect other medicinal products
Eintrag öffnenReagila · 4.5 · Potential for cariprazine to affect other medicinal products
Eintrag öffnenReagila · 4.5 · Potential for other medicinal products to affect cariprazine
Eintrag öffnenReagila · 4.5 · Potential for other medicinal products to affect cariprazine
Eintrag öffnenReagila · 4.8 · 10 patients treated with cariprazine, versus 2.0% in the placebo group. Parkinsonism was experienced in 7.8% a
Eintrag öffnenReagila · 4.8 · ADRs based upon pooled data from cariprazine schizophrenia studies are shown by system organ class and by pref
Eintrag öffnenReagila · 4.8 · ADRs based upon pooled data from cariprazine schizophrenia studies are shown by system organ class and by pref
Eintrag öffnenReagila · 4.8 · In the negative symptom study EPS was reported in 14.3% in the cariprazine group and 11.7% in the risperidone
Eintrag öffnen